Roozbehkia, Maryam <br/><br/>
The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients.  [electronic resource] 

 -  International immunopharmacology  Nov 2017 
 - 191-196 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2017.08.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Female<br/>Hexuronic Acids--therapeutic use<br/>Humans<br/>Immunity, Innate<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Mitogen-Activated Protein Kinase 14--genetics<br/>Myeloid Differentiation Factor 88--genetics<br/>NF-kappa B--metabolism<br/>Signal Transduction<br/>Spondylitis, Ankylosing--drug therapy<br/>Toll-Like Receptor 2--metabolism<br/>Toll-Like Receptor 4--metabolism<br/>Treatment Outcome<br/>Young Adult